igf-1 lr3 side effects injection peptide: complete guide to insulin-like growth factor for muscle growth Side Effects of IGF-1 LR3

Molecular analysis of the massive GSH transport mechanism mediated by the human Multidrug Resistant Protein 1/ABCC1

mean treatment difference -0.02 log 10 copies/mL, 95% confidence interval -0.62, 0.57, p=0.94), the median number of supplemental oxygen-free days (presatovir 26 [IQR 10, 28] days, placebo 28 [IQR 9, 28] days, p=0.84), the proportion of subjects developing respiratory failure (presatovir 3, placebo 3, p=0.98), or all-cause mortality (presatovir 0, placebo 2, p=0.19)

doi:10.1016/s0076-6879(02)45028-8

Pak 26, 260262

Increased exposure of parasite antigens at the surface of adult male schistosoma mansoni exposed to praziquantel in vitro